Marchex INC 8-K filings

Marchex announced its second quarter 2026 financial results, reporting improved Adjusted EBITDA and early positive momentum following the Archenia acquisition, though revenue saw a slight decrease.

Marchex reported Q1 2026 results with a narrowed net loss and improved Adjusted EBITDA, driven by AI integration and progress on the Archenia acquisition.

Marchex, Inc. has entered into a sublease agreement for its Seattle office space, resulting in a non-cash impairment charge of approximately $203,000.

Marchex, Inc. has entered into a settlement agreement to resolve a civil action, agreeing to pay $1.75 million over three installments.

Marchex reports Q4 2025 revenue decline and increased net loss, while outlining positive 2026 outlook and Archenia acquisition progress.

Marchex, Inc.'s Compensation Committee approved annual cash bonuses for its executive officers for fiscal year 2025.

Marchex, Inc. announced the re-election of its directors and new compensation arrangements including stock options and quarterly cash payments following its 2025 annual meeting.

Marchex announced an agreement in principle to acquire AI-driven Archenia for $10 million and contingent shares, alongside reporting a Q3 2025 revenue decline but improved Adjusted EBITDA.

Marchex, Inc. announced updated base salaries and significant equity grants for its President, COO, and CFO, alongside revised employment terms.

Marchex, Inc. announced a significant executive leadership reshuffle, including the departure of its CEO and the appointment of new President, COO, and CFO.

Marchex reports improved net income and Adjusted EBITDA for Q2 2025, driven by operational efficiencies and strategic platform migration, despite a slight revenue decline.

Marchex reports its Q1 2025 financial results, showcasing its transition to an AI-powered prescriptive analytics leader and announcing a new share repurchase program.

Marchex, Inc. approved restricted stock unit grants to its CEO, Chief Revenue Officer, and Principal Financial Officer on March 20, 2025, as part of its annual compensation review.

Marchex reports a slight revenue decrease for Q4 and full year 2024, but highlights progress in AI solutions and strategic partnerships to drive future growth.

Marchex, Inc. announced the termination of employment of Chief Financial Officer Holly Aglio, effective January 10, 2025, and the appointment of Brian Nagle as Principal Financial Officer.

Marchex Inc. has entered into a consulting agreement with Vice Chairman Michael Arends, including a $180,000 payment and a stock option grant.

Marchex, Inc. has granted stock options to its directors and established a quarterly cash payment for their annual board service.

Marchex announced its Q3 2024 financial results, highlighting progress in AI-driven product innovation and strategic partnerships, while also providing an outlook for Q4 2024 and initial 2025 expectations.

Marchex announced its Q2 2024 financial results, showing a slight decrease in revenue but a significant improvement in profitability compared to the same period last year.

Marchex, Inc. has granted stock options to its CEO and Chief Revenue Officer and updated their employment terms, including vesting schedules and severance benefits.

Marchex announced its Q1 2024 financial results, showing a slight decrease in revenue but a significant reduction in net loss compared to the same period last year.

Marchex announced its first quarter 2024 financial results, showing a slight decrease in revenue but a significant reduction in net loss compared to the same period last year.

Marchex announced its Q4 and full year 2023 financial results, showing a slight revenue increase in Q4 but a full year revenue decrease, alongside a focus on AI and strategic growth initiatives for 2024.